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Due to the overprescribing of antibiotics bacteria have adapted and developed 
mechanisms to combat the antimicrobial agents. One example is Staphylococcus aureus, 
which causes common skin infections, and can be easily treated. But amidst the abuse 
of antibiotics, S. aureus has become resistant to most known antibiotics; resistant strains 
are termed Methicillin-resistant Staphylococcus aureus (MRSA). This is a major concern 
in hospitals where the bacteria evolve under constant pressure developing multi-drug 
resistance. Thus significant efforts have been made to develop either stronger antibiotics 
or investigating alternate pathways to target the resistant strains.  The mevalonate 
pathway appears to be critical for the survival of many bacteria including S. aureus.  
Recently, Matsumoto et. al. concluded that the mevalonate pathway is essential for cell 
wall synthesis.  Gram-positive bacteria have a thick cell wall layer and interrupting 
assembly of this layer generates antimicrobial activity.  The same group identified 
Farnesyl diphosphate as an important intermediate in cell wall synthesis and depletion of 
this molecule compromises the cell wall layer making the bacteria susceptible to osmotic 
fluctuations. In another study, Qingrong Huang and co-workers, isolated a dipeptide 
pyrophosphate from a common beverage -kefir. This peptide inhibited fungi and several 
Gram-positive bacteria and showed a synergistic effect with Erythromycin in Gram-
negative bacteria. We hypothesize that this dipeptide competes with the Farnesyl 
diphosphate in the synthesis of the cell wall.  To test our hypothesis, we are synthesizing 
various analogs of the dipeptide pyrophosphate. These molecules will help us deduce the 
structural elements required for activity. We will then test our hypothesis by probing the 
mechanism of action. This poster highlights our synthetic efforts at building the compound 
library. 
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